Target Price | $40.00 |
Price | $3.69 |
Potential |
984.01%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Xenetic Biosciences, Inc. price target 2025.
The average Xenetic Biosciences, Inc. target price is $40.00.
This is
984.01%
register free of charge
|
|
A rating was issued by 1 analysts: 0 Analysts recommend Xenetic Biosciences, Inc. to buy, 1 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Xenetic Biosciences, Inc. stock has an average upside potential 2025 of
984.01%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 2.54 | 2.20 |
48.54% | 13.39% | |
EBITDA Margin | -177.95% | -281.82% |
54.51% | 58.37% | |
Net Margin | -164.31% | -455.00% |
60.42% | 176.92% |
1 Analyst has issued a sales forecast Xenetic Biosciences, Inc. 2024 . The average Xenetic Biosciences, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Xenetic Biosciences, Inc. 2024 . The average Xenetic Biosciences, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
The average Xenetic Biosciences, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
2023 | $-4.2m | 41.21% |
---|---|---|
2024 |
$-10.0m
139.85%
Unlock
|
2023 | -164.31% | 60.42% |
---|---|---|
2024 |
-455.00%
176.92%
Unlock
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.71 | -6.50 |
41.21% | 139.85% | |
P/E | negative | |
EV/Sales | negative |
The average Xenetic Biosciences, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
2023 | $-2.71 | 41.21% |
---|---|---|
2024 |
$-6.50
139.85%
Unlock
|
Current | -1.39 | 39.00% |
---|---|---|
2024 |
-0.57
58.99%
Unlock
|
Based on analysts' sales estimates for 2024, the Xenetic Biosciences, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Xenetic Biosciences, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.